Mainz Biomed B.V.
$0.70-5.07%($-0.04)
TickerSpark Score
37/100
20
Valuation
40
Profitability
55
Growth
40
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYNZ research report →
52-Week Range3% of range
Low $0.55
Current $0.70
High $5.34
Companymainzbiomed.com
Mainz Biomed B. V. , a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics.
- CEO
- Guido Baechler
- IPO
- 2021
- Employees
- 19
- HQ
- Mainz, DE
Price Chart
-84.29% · this period
Valuation
- Market Cap
- $2.86M
- P/E
- -1.24
- P/S
- 78.06
- P/B
- 31.31
- EV/EBITDA
- -2.86
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 72.58%
- Op Margin
- -2414.04%
- Net Margin
- -3018.31%
- ROE
- -484.76%
- ROIC
- -403.51%
Growth & Income
- Revenue
- $537.08K · -39.92%
- Net Income
- $-16,210,718 · 25.13%
- EPS
- $-2.70 · 87.92%
- Op Income
- $-13,498,818
- FCF YoY
- 36.69%
Performance & Tape
- 52W High
- $5.34
- 52W Low
- $0.55
- 50D MA
- $0.97
- 200D MA
- $1.38
- Beta
- 0.32
- Avg Volume
- 554.37K
Get TickerSpark's AI analysis on MYNZ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 22, 26 | Lazar David E. | other | 1,000,000 |
| Apr 22, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 0 |
| Feb 13, 26 | Caragol William J | other | 290,000 |
| Feb 13, 26 | Dreismann Heinrich | other | 45,000 |
| Feb 13, 26 | Tibbitts Gregory J | other | 45,000 |
| Feb 13, 26 | BAECHLER GUIDO | other | 440,000 |
Our MYNZ Coverage
We haven't published any research on MYNZ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MYNZ Report →